GSK plc. Registered in England and Wales No. 3888792.Registered office: 79 New Oxford Street, London. United Kingdom. WC1A 1DG> Modern Slavery Act statement 2023 (PDF - 139.1KB) GSK websites Locations selector Social media directory GSKPro for healthcare professionals GSK study ...
Annual Summary 2017 (PDF - 953.4KB) Responsible Business Supplement 2017 (PDF - 3.6MB) 20-F 2017 (PDF - 8.9MB) 20-FA Amendment No.1 2017 (PDF - 42.3KB) Xbrl interactive data file 2017 (ZIP - 685.6KB) GlaxoSmithKline Capital plc Annual Report 2017 (PDF - 741.4KB) Download ...
GlaxoSmithKline Pharmaceuticals Limited | Annual Report 2021-22 GSK plc at a glance Our purpose We unite science, technology and talent to get ahead of disease together For health impact + shareholder returns + thriving people About our new logo The new logo reflects our new purpose and growth ...
Issued: 8 March 2022, London UK GlaxoSmithKline plc Annual Report 2021 on Form 20-F In accordance with Section 203.01 of the New York Stock Exchange Listed Company Manual, GlaxoSmithKline plc ("GSK") announces that on 8 March 2022 it filed with the Securities and Exchange Commission an Annual...
GSK plc (LSE/NYSE: GSK) today announced new data from the AReSVi-006 (AdultRespiratorySyncytialVirus) phase III trial evaluating the efficacy of a single dose of AREXVY (respiratory syncytial virus vaccine, adjuvanted) against lower respirator...
GSK Annual Report 2023 Quarterly results You might also like Our products We research and develop a broad range of innovative products Pharmaceuticals and Vaccines Career opportunities at GSK Discover the work we do and the opportunities that exist, from research and development through to making our...
GSK plc (LSE/NYSE: GSK) today announced it has completed the acquisition of Affinivax, Inc (Affinivax), a clinical-stage biopharmaceutical company based in Cambridge (Boston, Massachusetts). Affinivax has pioneered the development of a novel class of vaccines, the most advanced of which are next...
GlaxoSmithKline plc is one of the leading pharmaceutical companies worldwide. The multinational company is headquartered in London, UK. In 2023, the company generated a total of some 30.3 billion British pounds of revenue, compared to 29.3 billion in 2022. The lower revenue figure reflects the de...
GSK plc. Registered in England and Wales No. 3888792. Registered office: 980 Great West Road, Brentford, Middlesex, TW8 9GS, United Kingdom. Modern Slavery Act statement 2022 (PDF - 189.7KB) GSK websites Locations selector GSKPro for healthcare professionals GSK study register Supplier...
GSK plc (LSE/NYSE: GSK) today announced it has completed the acquisition of Affinivax, Inc (Affinivax), a clinical-stage biopharmaceutical company based in Cambridge (Boston, Massachusetts). Affinivax has pioneered the development of a novel class of vaccines, the most advanced of which are next...